Ovarian cancer screening and peritoneal carcinomatosis: Standards, 'omics' and miRNAs for personalized management

Expert Review of Molecular Diagnostics

Volumn 11, Issue 5, 2011, Pages 465-467

  Spiliotis, John ^a   Halkia, Eugenia ^a   Roukos, Dimitrios H ^b,c  

^a METAXA Cancer Memorial Hospital   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

biomarker; genomics; hyperthermic intraperitoneal chemotherapy; ovarian cancer; peritoneal carcinomatosis; proteomics; screening

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; MICRORNA;

CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CARCINOMATOUS PERITONITIS; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; INCIDENCE; MORTALITY; OVARY CANCER; PREDICTIVE VALUE; REVIEW; TRANSVAGINAL ECHOGRAPHY;

CA-125 ANTIGEN; EARLY DETECTION OF CANCER; FEMALE; GENOMICS; HUMANS; METABOLOMICS; MICRORNAS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROTEOMICS;

EID: 79959809145     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.29     Document Type: Review

References (21)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 60(5), 277-300 (2010
3. Clarke-Pearson DL. Clinical practice. Screening for ovarian cancer. N. Engl. J. Med. 361(2), 170-177 (2009
4. Badgwell D, Bast RC Jr. Early detection of ovarian cancer. Dis. Markers 23(5-6), 397-410 (2007
5. Yachida S, Jones S, Bozic I et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467(7319), 1114-1117 (2010
6. Brower V. Biomarkers: portents of malignancy. Nature 471(7339), S19-S21 (2011
7. Buchen L. Cancer: missing the mark. Nature 471(7339), 428-432 (2011
8. Visintin I, Feng Z, Longton G et al. Diagnostic markers for early detection of ovarian cancer. Clin. Cancer Res. 14, 1065-1072 (2008
9. Fung ET. A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance. Clin. Chem. 56, 327-329 (2010
10. Jacobs IJ, Skates SJ, MacDonald N et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 353, 1207-1210 (1999
11. Cramer DW, Bast RC Jr, Berg CD et al. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev. Res. 4(3), 365-374 (2011
12. Zhu CS, Pinsky PF, Cramer DW et al. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev. Res. 4(3), 375-383 (2011
13. Rodriguez H, Tezak Z, Mesri M et al. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin. Chem. 56(2), 237-243 (2010
14. du Bois A, Quinn M, Thigpen T et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004Ann. Oncol. 16(Suppl. 8), 7-12 (2005)
15. Deraco M, Baratti D, Laterza B et al. Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. Eur. J. Surg. Oncol. 37(1), 4-9 (2011
16. Vergote I, Tropé CG, Amant F et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N. Engl. J. Med. 363(10), 943-953 (2010
17. Armstrong DK, Bundy B, Wenzel L. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N. Engl. J. Med. 354(1), 34-43 (2006
18. Lander ES. Initial impact of the sequencing of the human genome. Nature 470(7333), 187-197 (2011
19. Yang N, Kaur S, Volinia S et al. MicroRNA microarray identifies let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 68(24), 10307-10314 (2008
20. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 9(10), 775-789 (2010
21. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646-674 (2011).